Dr. Kelly received his medical training at the University College, Cork, Ireland and completed his medical residency in Cork University Hospital Ireland and subsequently completed a hematology fellowship with the Royal College of Pathologists Dublin Ireland. He has recently completed an advanced hematology fellowship in drug development at the Institute for Drug Development, San Antonio and is now an assistant Professor at the University of Texas Health Science Center, San Antonio. Throughout this time he has focused his pre-clinical and clinical research efforts on developing therapies for patients suffering from treatment-resistant of leukemia, lymphoma, and multiple myeloma.